Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it.

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.

The grant will fund a phase 1 placebo-controlled trial in healthy men, including developing an oral formulation, establishing manufacturing protocols and evaluating safety.

Chronic stress may contribute to the pain and urinary symptoms experienced by people with interstitial cystitis/bladder pain syndrome by triggering changes in the bladder and nervous system, according to Weill Cornell investigators.

Folic acid does not elevate toxic formaldehyde in the body, according to a new study on mice and human cancer patients who consumed high doses. 

Seven Cornell research teams have received Center for Advanced Technology grants to advance early-stage life science technologies through collaborations with biotechnology companies across New York state. Awardees include projects on fertility technology and decreasing children’s exposure to antibiotics.

The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

A new Duffield Engineering biomedical engineering course will challenge students to investigate real-world failures in women’s health technologies and identify opportunities for better design.

A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the biological process that forms eggs and sperm in mammals.

A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment. 

A new Cornell-led report shows protecting nutrition now depends on integrating food and health systems as climate shocks strain both at once.

The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, according to a new study.